Argon plasma coagulation is effective for prevention of recurrent esophageal varices after endoscopic injection sclerotherapy: Single-center case-control study

Background and Aim Esophageal varices are usually treated with endoscopic injection sclerotherapy (EIS) or endoscopic band ligation (EBL). However, frequent recurrences of varices after those procedures have been problematic. Argon plasma coagulation (APC) after EIS may be effective for preventing v...

Full description

Saved in:
Bibliographic Details
Published in:Digestive endoscopy Vol. 28; no. 1; pp. 42 - 49
Main Authors: Deguchi, Hisanobu, Kato, Jun, Maeda, Yoshimasa, Moribata, Kosaku, Shingaki, Naoki, Niwa, Toru, Inoue, Izumi, Maekita, Takao, Iguchi, Mikitaka, Tamai, Hideyuki, Ichinose, Masao
Format: Journal Article
Language:English
Published: Australia Blackwell Publishing Ltd 01-01-2016
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background and Aim Esophageal varices are usually treated with endoscopic injection sclerotherapy (EIS) or endoscopic band ligation (EBL). However, frequent recurrences of varices after those procedures have been problematic. Argon plasma coagulation (APC) after EIS may be effective for preventing varix recurrence and, in recent years, we have routinely carried out APC after EIS. The aim of the present study was to verify the effectiveness of APC for preventing recurrence of varices after EIS. Methods A case–control study was carried out using a historical control cohort in a single center. The varix recurrence rate in 62 patients (34 men and 28 women, median age; 69 years) who underwent APC after EIS for hemorrhagic or risky esophageal varices (APC group) was compared with that of control patients who did not undergo APC after EIS (control group). Age‐, sex‐, and liver function‐matched two control subjects were selected for one case subject (control group). Recurrence of varices was defined as rupture of varices or reappearance of risky varices. Results The 1‐year and 2‐year recurrence rates of the APC group were 9.7% and 11.3%, respectively. In contrast, the rates of the control group were 29.0% and 34.7%, respectively. Kaplan–Meier curves showed a significantly lower recurrence rate in the APC group (P = 0.013, log–rank test). No APC‐related severe adverse events were observed. Conclusion APC after EIS was safe and could significantly prevent recurrence of esophageal varices. Therefore, the addition of APC should be routinely carried out after EIS.
Bibliography:Supporting info item
ArticleID:DEN12538
istex:95ABCD9091816B1102955BE488BEC646EEC7895C
ark:/67375/WNG-XCZ9LZTS-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0915-5635
1443-1661
DOI:10.1111/den.12538